Nemolizumab for LS
NCT07704775
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Lichen Sclerosus of Vulva
Interventions
BIOLOGICAL:
Nemolizumab 30 mg
Sponsor
University of Texas Southwestern Medical Center